Drugs & Targets Tesaro receives European approval of Zejula for recurrent ovarian cancer December 01, 2017Vol.43 No.44
Drugs & Targets G1 Therapeutics and AstraZeneca enter clinical trials collaboration in NSCLC December 01, 2017Vol.43 No.44
Drugs & Targets ITUS Corp. Moffitt enter into CRADA to develop CAR-T technology December 01, 2017Vol.43 No.44
Drugs & Targets FDA approves adjuvant indication for Sutent in renal cell carcinoma November 17, 2017Vol.43 No.43
Drugs & Targets FDA approves obinutuzumab for previously untreated follicular lymphoma November 17, 2017Vol.43 No.43
Drugs & Targets FDA approves Genentech’s Hemlibra to prevent bleeding in hemophilia A November 17, 2017Vol.43 No.43
Drugs & Targets FDA has accepts Genentech’s BLA for a subcutaneous formulation of rituximab in blood cancer indications November 11, 2017Vol.42 No.42
Drugs & Targets Alecensa gets FDA approval for ALK-positive metastatic NSCLC November 10, 2017Vol.43 No.42
